
Scott Long
Examiner (ID: 10754, Phone: (571)272-9048 , Office: P/1633 )
| Most Active Art Unit | 1633 |
| Art Unit(s) | 1633 |
| Total Applications | 882 |
| Issued Applications | 557 |
| Pending Applications | 29 |
| Abandoned Applications | 301 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6054533
[patent_doc_number] => 20110110893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-12
[patent_title] => 'THERAPEUTIC AGENT FOR ANAEROBIC DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/988181
[patent_app_country] => US
[patent_app_date] => 2009-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 15558
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20110110893.pdf
[firstpage_image] =>[orig_patent_app_number] => 12988181
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/988181 | Therapeutic agent for anaerobic diseases | Apr 16, 2009 | Issued |
Array
(
[id] => 5458780
[patent_doc_number] => 20090258932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-15
[patent_title] => 'Lyophilized DNA Formulations for Enhanced Expression of Plasmid DNA'
[patent_app_type] => utility
[patent_app_number] => 12/421425
[patent_app_country] => US
[patent_app_date] => 2009-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10569
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20090258932.pdf
[firstpage_image] =>[orig_patent_app_number] => 12421425
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/421425 | Lyophilized DNA Formulations for Enhanced Expression of Plasmid DNA | Apr 8, 2009 | Abandoned |
Array
(
[id] => 5495332
[patent_doc_number] => 20090263360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-22
[patent_title] => 'Neuronal progenitors from feeder-free human embryonic stem cell culture'
[patent_app_type] => utility
[patent_app_number] => 12/384272
[patent_app_country] => US
[patent_app_date] => 2009-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13958
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20090263360.pdf
[firstpage_image] =>[orig_patent_app_number] => 12384272
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/384272 | Neuronal progenitors from feeder-free human embryonic stem cell culture | Apr 1, 2009 | Issued |
Array
(
[id] => 6149340
[patent_doc_number] => 20110020935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-27
[patent_title] => 'METHOD OF GENE TRANSFER INTO CELLS USING ELECTROSPRAY AND APPARATUS THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 12/934139
[patent_app_country] => US
[patent_app_date] => 2009-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5806
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20110020935.pdf
[firstpage_image] =>[orig_patent_app_number] => 12934139
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/934139 | METHOD OF GENE TRANSFER INTO CELLS USING ELECTROSPRAY AND APPARATUS THEREFOR | Mar 23, 2009 | Abandoned |
Array
(
[id] => 7540411
[patent_doc_number] => 08058254
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-15
[patent_title] => 'DNA vaccines encoding heat shock proteins'
[patent_app_type] => utility
[patent_app_number] => 12/396401
[patent_app_country] => US
[patent_app_date] => 2009-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 13467
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/058/08058254.pdf
[firstpage_image] =>[orig_patent_app_number] => 12396401
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/396401 | DNA vaccines encoding heat shock proteins | Mar 1, 2009 | Issued |
Array
(
[id] => 5385766
[patent_doc_number] => 20090227011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-10
[patent_title] => 'METHODS OF PURIFYING PLASMID DNA'
[patent_app_type] => utility
[patent_app_number] => 12/394397
[patent_app_country] => US
[patent_app_date] => 2009-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11756
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20090227011.pdf
[firstpage_image] =>[orig_patent_app_number] => 12394397
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/394397 | METHODS OF PURIFYING PLASMID DNA | Feb 26, 2009 | Abandoned |
Array
(
[id] => 6174718
[patent_doc_number] => 20110177170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-21
[patent_title] => ' IMPLANTABLE NEUROENDOPROSTHETIC SYSTEM, A METHOD OF PRODUCTION THEREOF AND A METHOD OF RECONSTRUCTIVE NEUROSURGICAL OPERATION'
[patent_app_type] => utility
[patent_app_number] => 13/121069
[patent_app_country] => US
[patent_app_date] => 2009-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12098
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20110177170.pdf
[firstpage_image] =>[orig_patent_app_number] => 13121069
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/121069 | IMPLANTABLE NEUROENDOPROSTHETIC SYSTEM, A METHOD OF PRODUCTION THEREOF AND A METHOD OF RECONSTRUCTIVE NEUROSURGICAL OPERATION | Feb 12, 2009 | Abandoned |
Array
(
[id] => 6213873
[patent_doc_number] => 20110136738
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-09
[patent_title] => 'Alternatively Transcribed Genes Associated with Schizophrenia'
[patent_app_type] => utility
[patent_app_number] => 12/867389
[patent_app_country] => US
[patent_app_date] => 2009-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 39398
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20110136738.pdf
[firstpage_image] =>[orig_patent_app_number] => 12867389
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/867389 | Alternatively Transcribed Genes Associated with Schizophrenia | Feb 10, 2009 | Abandoned |
Array
(
[id] => 6584641
[patent_doc_number] => 20100047813
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-25
[patent_title] => 'BIOLUMINESCENCE RESONANCE ENERGY TRANSFER (BRET) SYSTEMS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/365984
[patent_app_country] => US
[patent_app_date] => 2009-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 26913
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20100047813.pdf
[firstpage_image] =>[orig_patent_app_number] => 12365984
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/365984 | Bioluminescence resonance energy transfer (BRET) systems and methods of use thereof | Feb 4, 2009 | Issued |
Array
(
[id] => 6024346
[patent_doc_number] => 20110052672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'TREATMENTS OF DISEASE OR DISORDERS USING NANOPARTICLES FOR FOCUSED HYPERTHERMIA TO INCREASE THERAPY EFFICACY'
[patent_app_type] => utility
[patent_app_number] => 12/863163
[patent_app_country] => US
[patent_app_date] => 2009-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9565
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20110052672.pdf
[firstpage_image] =>[orig_patent_app_number] => 12863163
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/863163 | TREATMENTS OF DISEASE OR DISORDERS USING NANOPARTICLES FOR FOCUSED HYPERTHERMIA TO INCREASE THERAPY EFFICACY | Jan 15, 2009 | Abandoned |
Array
(
[id] => 6292509
[patent_doc_number] => 20100239563
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-23
[patent_title] => 'PHARMACEUTICAL COMPOSITION FOR THE PROPHYLAXIS AND/OR TREATMENT OF VIRAL DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/343461
[patent_app_country] => US
[patent_app_date] => 2008-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9403
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20100239563.pdf
[firstpage_image] =>[orig_patent_app_number] => 12343461
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/343461 | PHARMACEUTICAL COMPOSITION FOR THE PROPHYLAXIS AND/OR TREATMENT OF VIRAL DISEASES | Dec 22, 2008 | Abandoned |
Array
(
[id] => 5928982
[patent_doc_number] => 20110038941
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-17
[patent_title] => 'Lipid Nanoparticle Compositions and Methods of Making and Using the Same'
[patent_app_type] => utility
[patent_app_number] => 12/810900
[patent_app_country] => US
[patent_app_date] => 2008-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 66
[patent_figures_cnt] => 66
[patent_no_of_words] => 39274
[patent_no_of_claims] => 94
[patent_no_of_ind_claims] => 63
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20110038941.pdf
[firstpage_image] =>[orig_patent_app_number] => 12810900
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/810900 | Lipid Nanoparticle Compositions and Methods of Making and Using the Same | Dec 22, 2008 | Abandoned |
Array
(
[id] => 5385182
[patent_doc_number] => 20090226427
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-10
[patent_title] => 'NOVEL PHARMACEUTICAL COMPOSITIONS FOR MODULATING ANGIOGENESIS'
[patent_app_type] => utility
[patent_app_number] => 12/338062
[patent_app_country] => US
[patent_app_date] => 2008-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 15875
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20090226427.pdf
[firstpage_image] =>[orig_patent_app_number] => 12338062
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/338062 | NOVEL PHARMACEUTICAL COMPOSITIONS FOR MODULATING ANGIOGENESIS | Dec 17, 2008 | Abandoned |
Array
(
[id] => 5575042
[patent_doc_number] => 20090142403
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-04
[patent_title] => 'ORGAN REGENERATION DEVICE'
[patent_app_type] => utility
[patent_app_number] => 12/325015
[patent_app_country] => US
[patent_app_date] => 2008-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 15497
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20090142403.pdf
[firstpage_image] =>[orig_patent_app_number] => 12325015
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/325015 | Organ regeneration device | Nov 27, 2008 | Issued |
Array
(
[id] => 5557819
[patent_doc_number] => 20090269396
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-29
[patent_title] => 'DUAL ACTION, INHALED FORMULATIONS PROVIDING BOTH AN IMMEDIATE AND SUSTAINED RELEASE PROFILE'
[patent_app_type] => utility
[patent_app_number] => 12/261946
[patent_app_country] => US
[patent_app_date] => 2008-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 15344
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20090269396.pdf
[firstpage_image] =>[orig_patent_app_number] => 12261946
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/261946 | Dual action, inhaled formulations providing both an immediate and sustained release profile | Oct 29, 2008 | Issued |
Array
(
[id] => 5324255
[patent_doc_number] => 20090062245
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-05
[patent_title] => 'Modulation of Neurodegenerative Diseases Through The Progesterone Receptor'
[patent_app_type] => utility
[patent_app_number] => 12/255168
[patent_app_country] => US
[patent_app_date] => 2008-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10152
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20090062245.pdf
[firstpage_image] =>[orig_patent_app_number] => 12255168
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/255168 | Modulation of Neurodegenerative Diseases Through The Progesterone Receptor | Oct 20, 2008 | Abandoned |
Array
(
[id] => 8749095
[patent_doc_number] => 08414924
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-09
[patent_title] => 'Preparation for treating heart disease used in cell therapy'
[patent_app_type] => utility
[patent_app_number] => 12/681940
[patent_app_country] => US
[patent_app_date] => 2008-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 16
[patent_no_of_words] => 12375
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12681940
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/681940 | Preparation for treating heart disease used in cell therapy | Oct 8, 2008 | Issued |
Array
(
[id] => 6306194
[patent_doc_number] => 20100069254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-18
[patent_title] => 'Cell Culture Model for Demyelination/Remyelination'
[patent_app_type] => utility
[patent_app_number] => 12/211685
[patent_app_country] => US
[patent_app_date] => 2008-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6767
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20100069254.pdf
[firstpage_image] =>[orig_patent_app_number] => 12211685
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/211685 | Cell Culture Model for Demyelination/Remyelination | Sep 15, 2008 | Abandoned |
Array
(
[id] => 5429072
[patent_doc_number] => 20090088382
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-02
[patent_title] => 'Use of the cathelicidin LL-37 and derivatives therof for wound healing'
[patent_app_type] => utility
[patent_app_number] => 12/232215
[patent_app_country] => US
[patent_app_date] => 2008-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11538
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20090088382.pdf
[firstpage_image] =>[orig_patent_app_number] => 12232215
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/232215 | Use of the cathelicidin LL-37 and derivatives therof for wound healing | Sep 11, 2008 | Issued |
Array
(
[id] => 5435512
[patent_doc_number] => 20090170099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-02
[patent_title] => 'Use of Regulatory Sequences for Specific, Transient Expression in Neuronal Determined Cells'
[patent_app_type] => utility
[patent_app_number] => 12/209974
[patent_app_country] => US
[patent_app_date] => 2008-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 57
[patent_figures_cnt] => 57
[patent_no_of_words] => 46631
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20090170099.pdf
[firstpage_image] =>[orig_patent_app_number] => 12209974
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/209974 | Use of regulatory sequences for specific, transient expression in neuronal determined cells | Sep 11, 2008 | Issued |